Drug intelligence / Profile preview

tianeptine hemioxalate

Development stage
Phase 2
Lead developer
Tonix Pharmaceuticals
Modality
Small Molecules
Administration
Oral
01

Overview

Tianeptine hemioxalate is a novel salt form of the atypical tricyclic antidepressant tianeptine. It is being developed as an extended-release oral tablet for once-daily dosing in the treatment of major depressive disorder. The drug acts primarily by modulating glutamatergic neurotransmission and restoring neuroplasticity in stress-atrophied neurons, rather than through direct effects on monoaminergic neurotransmitter systems. Tianeptine also exhibits weak agonist activity at the μ-opioid receptor, which may contribute to its antidepressant and anxiolytic effects but also carries potential for abuse at high doses. The proprietary formulation aims to improve stability and manufacturability compared to previous salt forms[3][5][6].

Brand names
TNX-601 ERTNX601 ERTNX 601 ER
Other names
tianeptine oxalateZaZaTianna Red
02

Targets

PPARD (Peroxisome proliferator–activated receptor delta)DOR (Opioid Receptor Delta 1)MOR (Mu opioid receptor)PPARG (Peroxisome proliferator-activated receptor gamma)

Beyond the preview

Go deeper on tianeptine hemioxalate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on tianeptine hemioxalate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call